Profile
David Feltquate currently works at iTeos Therapeutics, Inc., as Chief Medical Officer from 2024.
Dr. Feltquate also formerly worked at Novartis, Inc., as Chairman-Precision Medicine Leadership Team from 2020 to 2021, Bristol Myers Squibb Co., as Head-Early Clinical Development from 2016 to 2019, and Palleon Pharmaceuticals, Inc., as Chief Medical Officer from 2021 to 2024.
Dr. Feltquate received his undergraduate degree from Massachusetts Institute of Technology and doctorate degree from UMass Chan Medical School.
David Feltquate active positions
| Companies | Position | Start |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2024-08-04 |
Former positions of David Feltquate
| Companies | Position | End |
|---|---|---|
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Chief Tech/Sci/R&D Officer | 2024-06-30 |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Corporate Officer/Principal | 2021-05-31 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2019-09-30 |
Training of David Feltquate
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
UMass Chan Medical School
UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Health Technology |
iTeos Therapeutics, Inc.
iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
- Stock Market
- Insiders
- David Feltquate
















